Skip to main content
Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
580.57
-13.18 (-2.22%)
Feb 4, 2025, 4:00 PM EST - Market closed

Thermo Fisher Revenue by Segment
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Laboratory Products
23.16B 22.94B 22.93B 23.00B 23.04B 23.27B 23.13B 22.83B
Laboratory Products Growth
0.50% -1.41% -0.86% 0.74% 2.35% 12.09% 23.93% 36.66%
Life Sciences Solutions
9.63B 9.50B 9.54B 9.65B 9.98B 10.55B 11.08B 11.91B
Life Sciences Solutions Growth
-3.47% -10.02% -13.90% -18.99% -26.27% -27.89% -28.00% -23.93%
Analytical Instruments
7.46B 7.31B 7.26B 7.23B 7.26B 7.10B 6.97B 6.83B
Analytical Instruments Growth
2.75% 2.96% 4.15% 5.83% 9.65% 9.78% 10.20% 10.15%
Speciality Diagnostics
4.51B 4.46B 4.41B 4.41B 4.41B 4.42B 4.40B 4.39B
Speciality Diagnostics Growth
2.43% 1.02% 0.39% 0.39% -7.52% -13.35% -18.45% -20.58%
Eliminations
-1.88B -1.84B -1.80B -1.79B -1.83B -1.92B -2.05B -2.16B

Operating Income by Segment
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Life Sciences Solutions
3.50B 3.45B 3.47B 3.42B 3.42B 3.57B 3.73B 4.24B
Life Sciences Solutions Growth
2.40% -3.37% -6.97% -19.28% -38.73% -45.50% -49.04% -45.01%
Laboratory Products
3.09B 3.07B 3.23B 3.31B 3.36B 3.39B 3.18B 3.05B
Laboratory Products Growth
-7.98% -9.56% 1.64% 8.67% 16.92% 34.52% 45.91% 57.53%
Analytical Instruments
1.96B 1.88B 1.89B 1.89B 1.91B 1.80B 1.72B 1.63B
Analytical Instruments Growth
2.52% 4.45% 10.44% 15.98% 26.61% 27.27% 32.95% 32.71%
Speciality Diagnostics
1.16B 1.15B 1.14B 1.14B 1.12B 1.07B 1.01B 951.00M
Speciality Diagnostics Growth
3.11% 7.68% 13.43% 19.66% 9.77% -4.04% -16.46% -21.08%

Operating Expense Breakdown
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Selling, General, and Administrative
7.00B 6.83B 6.67B 6.65B 6.57B 6.73B 6.90B 6.97B
Selling, General, and Administrative Growth
6.61% 1.43% -3.33% -4.47% -7.83% -7.12% -4.63% -2.00%
Amortization of Intangibles
1.95B 2.08B 2.21B 2.28B 2.34B 2.37B 2.38B 2.39B
Amortization of Intangibles Growth
-16.51% -12.25% -6.98% -4.56% -2.38% 4.32% 13.30% 22.86%
Research and Development
1.39B 1.34B 1.32B 1.32B 1.34B 1.40B 1.43B 1.45B
Research and Development Growth
3.96% -4.14% -8.16% -9.02% -9.11% -4.82% -2.65% 0.21%
Restructuring and Other
379.00M 231.00M 270.00M 376.00M 459.00M 434.00M 383.00M 224.00M
Restructuring and Other Growth
-17.43% -46.77% -29.50% 67.86% 302.63% 313.33% 325.56% 21.08%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.